Society for Neuroscience - Search

Skip Navigation

  • join logo Join
  • hands shaped like a yellow heart icon Give
  • advocate logo Advocate
  • publish logo Publish
  • Icon with thought bubbles Learn
Shop Sign In
SfN Logo 2025
  • Membership
    • Learn About Membership
      • Individual Member Benefits
      • Institutional Program Member Benefits
      • Sustaining Associate Member Benefits
      • Get Involved at SfN
    • Become a Member
      • Sponsorship Information for New Members
      • Membership Categories & Fees
      • Membership Fees for Developing Countries
      • Renew Individual Membership
    • Member Resources
      • Automatic Renewals
      • Frequently Asked Questions
      • Individual Member Directory
      • Member Obituaries and Memorial Donations
    • Learn About Local Chapters
      • Start or Reactivate a Chapter
      • Resources for Chapters
      • Submit Annual Report
      • Chapter Directory
      • Frequently Asked Questions
  • Meetings
    • Meetings Overview
    • Neuroscience 2025
      • Presenter Resources
      • Itinerary Planner and Mobile App
      • Virtual Component
      • Sessions and Events
      • Registration
      • Housing and Travel
      • Exhibits
      • FAQs
    • Global Events
      • SfN Virtual Events
    • Past and Future Annual Meetings
      • Neuroscience 2024
      • Neuroscience 2023
      • Search Past Annual Meeting Abstracts
      • Attendance Statistics
    • Meeting Policies and Guidelines
      • Code of Conduct at SfN Events
      • Growth and Opportunity Strategy
      • Photography & Recording Policy
      • Presenter Guidelines and Policies for SfN Events
    • Meeting Awards
      • Trainee Professional Development Award
      • International Travel Awards
      • FENS Member Awards to SfN Annual Meeting
      • IBRO Member Awards to SfN Annual Meeting
      • JNS Member Awards to SfN Annual Meeting
  • Careers
    • Careers Overview
    • Institutional Program (IP) Directory
    • NeuroJobs Career Center
      • Job Seekers
      • Employers
    • 2025 Graduate School Fair
    • Career Tools and Resources
      • Neuronline
      • Neurobiology of Disease Workshop
      • Responsible Conduct of Research Short Courses
      • Neuroscience Departments and Program Workshop
      • Global Funding Sources
    • Higher Education and Training
      • Core Competencies
      • Neuroscience Training Program Survey
    • Awards
      • Outstanding Career and Research Achievements
      • Early Career
  • Initiatives
    • Initiatives Overview
    • Awards
      • 2025 Award Recipients
      • Awards and Prizes FAQ
      • Trainee Professional Development Award
    • Neuroscience Scholars Program
    • Neuronline
      • Webinars
      • Articles
      • Videos
      • Podcasts
      • Collections
    • Resources to Stay Connected
      • SfN Zoom Backgrounds
    • Community
    • Women and Neuroscience
      • Increasing Women in Neuroscience (IWiN) Courses & Toolkit
      • Celebration of Women in Neuroscience Event
      • Awards
    • Animals in Research
      • Support for Members and Institutions
      • Tools and Resources
      • Resources for Medical Students
    • Public Education Programs
      • Resources for Educators
      • Brain Awareness Video Contest
      • Life of a Neuron Exhibit
  • Advocacy
    • Advocacy Overview
    • Advocacy Response
    • Advocacy Network
      • The NeuroAdvocate Challenge
      • Advocacy Action Center
      • Advocacy Best Practices
      • Advocacy Network News
      • Advocacy Training Seminars
    • US Advocacy Programs
      • Capitol Hill Day
      • Connect with Policymakers
      • Early Career Policy Ambassadors
      • Partner with a Local Chapter
      • Engage the Media
    • Global Advocacy Programs
      • Global Neuroscience Initiatives
      • Global Funding
      • North American Programs
    • Science Funding
      • Advocacy Videos
      • Advocacy Resources
      • US Neuroscience Initiatives
      • Funding Priorities and Processes
    • Policy Positions
      • Statements and Testimony
      • Sign-On Letters
  • Outreach
    • Outreach Overview
    • BrainFacts.org
    • Find a Neuroscientist
    • Brain Awareness Campaign
      • Webinar: The ABC's of BAW
      • How to Get Involved
    • Awards
      • Award for Education in Neuroscience
      • Next Generation Award
      • Chapter of the Year Award
      • Science Educator Award
  • Publications
    • Publications Overview
    • SfN News
    • JNeurosci
    • eNeuro
    • SfN Nexus
    • Neuroscience Quarterly
    • Annual Report
    • History of Neuroscience Autobiographical Chapters
  • About
    • About Overview
    • Mission and Strategic Plan
    • What We Do
      • Annual Report
      • Bylaws
      • Resolutions to the Bylaws
      • Environmental Commitment
      • Strategic Partners
      • History of SfN
    • SfN 50th Anniversary Celebration
    • NIH Public Health Service-Supported Funding Financial Conflict of Interest Policy
    • Volunteer
      • SfN Council
      • SfN Presidents
      • Committees
      • Elections
      • Call for Nominations
    • Professional Conduct
      • SfN Ethics Policy
      • Guidelines for Responsible Conduct Regarding Scientific Communication
      • Code of Conduct at SfN Events
      • Commitment to Scientific Integrity
      • Neuronline Digital Learning Community Guidelines
    • History of Neuroscience
      • Autobiographical Chapters
      • Autobiographical Videos of Prominent Neuroscientists
      • Classic Papers
      • Neuroscience History Resources
      • Robert Doty's Chapter on Neuroscience
    • Careers and Staff
      • Staff List
  1. Search

Filter

  • (2)
  • (1)
  • (3)
  • (6)
  • (8)
  • (1)
  • (574)
  • (3)
  • (2)
  • (8)
Filter
501 - 510 of 892 results
  • Abstract
    ATYPICAL PROTEIN KINASE C (PKC) COLOCALIZES WITH TAU- AND α-SYNUCLEIN-RELATED INCLUSIONS IN NEURODEGENERATIVE DISORDERS.
    Tau-associated filamentous aggregates are neuropathological hallmarks of Alzheimer’s disease (AD), Pick's disease (PiD), progressive supranuclear palsy (PSP), and corticobasal degeneration (CBD), whereas α-synuclein-positive Lewy bodies are features of Parkinson’s disease (PD) and dementia with Lewy bodies (DLB). Factors underlying the genesis and functional impact of these aggregates remain poorly understood. Protein kinase M zeta (PKMζ), the catalytic fragment of PKCζ, plays a key role in the maintenance of long-term potentiation, a widely studied model of memory and synaptic plasticity (Ling et al. Nat Neurosci 5:295, 2002). We have demonstrated an association of PKMζ and atypical PKCs (ι and ζ) with neurofibrillary tangles and Hirano bodies in AD (Crary et al. Soc Neurosci Abs, 2002). In the present study, we investigated the relationship of atypical PKCs and PKMζ to abnormal inclusions in PiD (n=2); PSP (n=3); CBD (n=3); and DLB with AD (n=3). Immunohistochemical study was performed on autopsy brain t...
    Nov 5, 2002
  • Abstract
    ACTIVATION OF CANNABINOID RECEPTORS CAUSES REGION-SPECIFIC INCREASES IN RGS4 mRNA LEVELS IN BRAIN.
    Recent evidence suggests that endogenous cannabinoids in the CNS inhibit neuronal activity and neurotransmitter release. These effects are mediated by Gi/o coupled CB1 receptors, which are abundantly expressed in cerebellum, hippocampus, cortex and basal ganglia. Additional evidence suggests that CB1 receptor signaling is negatively modulated in a use-dependent fashion. The novel regulators of G protein signaling (RGS) proteins have potent GTPase activating effects at Gi/o subunits and thus could subserve negative feedback of CB1R signaling. We are using several lines of investigation to test this hypothesis. Six hr after an acute injection of THC, or 24 hr after a 15 d regimen of daily THC injections, mice were killed and processed for in situ hybridization to RGS4 mRNA in sections of prefrontal cortex, striatum, and cerebellum. RGS4 mRNA levels were increased in entorhinal cortex and hippocampus with a trend towards increased expression in striatum, but not in thalamus, 6 hr after an acute injection of T...
    Nov 13, 2001
  • Abstract
    Effects of Oleamide on Food Intake and Sexual Behavior.
    Delta9-tetrahydrocannabinol and anandamide (ANA) are the vegetal and the animal marijuana, respectively. They promote overeating and affect sexual behavior. Oleamide (OLE) is an endogenous sleep-inducing lipid, with several cannabinoid-like properties. OLE effects on feeding and sexual behavior were evaluated and compared with those induced by ANA. Experiment 1. Food satiated male Wistar rats received intraperitoneal (i.p.) injections of OLE or ANA (0.5, 1.0, 2.0 and 4.0 mg/kg) or vehicle. Food intake was measured at 1, 2, and 3 hours following injection. Experiment 2. Male sexual behavior was evaluated in Wistar rats after the i.p. administration of OLE, ANA (doses as above) or vehicle. Experimental males were exposed to estrogenous + progesterone-induced receptive females, 15 min after the injection. Both food intake and sexual behavior tests were carried out during the first half of the dark phase. Results showed that all doses of OLE and ANA induced significant overeating, with only one exception, ANA ...
    Nov 13, 2001
  • Abstract
    Antioxidants prevent neurotoxicity in a binge-drinking model of alcoholism.
    Alcoholism causes neurological disorders such as memory loss and cognitive disfunction. Binge drinking, the repeated consumption of high levels of alcohol over a several day period, is a widespread form of alcoholism in society today. One of the mechanisms leading to alcohol-induced neurotoxicity appears to be oxidative stress. This study demonstrates that administration of antioxidants such as alpha tocopherol (Vitamin E), butylhydroxytoluene (BHT), and cannabidiol (CBD) significantly reduce neurotoxicity in the hippocampal-entorhinal complex of rats in a binge-type model of alcoholism. The diuretic furosemide has also been shown to prevent neurotoxicity in this model. The proposed mechanism of action was linked to the reduction of edema. Using the binge-model we compared furosemide with two similar compounds, bumetanide and L-644,711. L-644,711 has previously been shown to be protective in an edema-based model of brain injury. However, in the present study, furosemide was found to be neuroprotective whil...
    Nov 7, 2000
  • Cannabinoids Stimulate the TRP Channel-Dependent Release of Both Serotonin and Dopamine to Modulate Behavior in C. elegans | Journal of Neuroscience
    Cannabis sativa alters sensory perception and exhibits potential medicinal benefits. In mammals, cannabinoids activate two canonical receptors, CB1/CB2, as well additional receptors/ion channels whose overall contributions to cannabinoid signaling have yet to be fully assessed. In Caenorhabditis elegans , the endogenous cannabinoid receptor agonist, 2-arachidonoylglycerol (2-AG) activates a CB1 ortholog, NPR-19, to modulate behavior ([Oakes et al., 2017][1]). In addition, 2-AG stimulates the NPR-19 independent release of both serotonin (5-HT) and dopamine (DA) from subsets of monoaminergic neurons to modulate locomotory behaviors through a complex monoaminergic signaling pathway involving multiple serotonin and dopamine receptors. 2-AG also inhibits locomotion in remodeled monoamine receptor mutant animals designed to measure the acute release of either 5-HT or DA, confirming the direct effects of 2-AG on monoamine release. 2-AG-dependent locomotory inhibition requires the expression of transient receptor ...
    May 22, 2019 Mitchell Oakes
  • Abstract
    Pharmacological identification of a win55212-2- and anandamide-sensitive binding site
    Several studies suggest that cannabinoids induce biological effects through specific receptors distinct from the cloned CB1 and CB2 receptors. Of all the cannabinoid agonists currently available, the prototypical aminoalkylindole compound WIN55212-2 is ...
    Nov 7, 2007
  • Abstract
    C-truncating mutations in the charged multivesicular body protein 2B gene disrupt endosomal trafficking in frontotemporal lobar degeneration
    The charged multivesicular body protein 2B gene (CHMP2B) was recently identified as the gene responsible for frontotemporal lobar degeneration (FTLD) linked to the pericentromeric region of chromosome 3. To date, linkage to this region was unique to a l...
    Nov 5, 2007
  • Modulation of CaV2.1 Channels by the Neuronal Calcium-Binding Protein Visinin-Like Protein-2 | Journal of Neuroscience
    CaV2.1 channels conduct P/Q-type Ca2+ currents that are modulated by calmodulin (CaM) and the structurally related Ca2+-binding protein 1 (CaBP1). Visinin-like protein-2 (VILIP-2) is a CaM-related Ca2+-binding protein expressed in the neocortex and hippocampus. Coexpression of CaV2.1 and VILIP-2 in tsA-201 cells resulted in Ca2+ channel modulation distinct from CaM and CaBP1. CaV2.1 channels with β2a subunits undergo Ca2+-dependent facilitation and inactivation attributable to association of endogenous Ca2+/CaM. VILIP-2 coexpression does not alter facilitation measured in paired-pulse experiments but slows the rate of inactivation to that seen without Ca2+/CaM binding and reduces inactivation of Ca2+ currents during trains of repetitive depolarizations. CaV2.1 channels with β1b subunits have rapid voltage-dependent inactivation, and VILIP-2 has no effect on the rate of inactivation or facilitation of the Ca2+ current. In contrast, when Ba2+ replaces Ca2+ as the charge carrier, VILIP-2 slows inactivation. T...
    Jul 27, 2005 Nathan J. Lautermilch
  • Trip6 Promotes Dendritic Morphogenesis through Dephosphorylated GRIP1-Dependent Myosin VI and F-Actin Organization | Journal of Neuroscience
    Thyroid receptor-interacting protein 6 (Trip6), a multifunctional protein belonging to the zyxin family of LIM proteins, is involved in various physiological and pathological processes, including cell migration and tumorigenesis. However, the role of Trip6 in neurons remains unknown. Here, we show that Trip6 is expressed in mouse hippocampal neurons and promotes dendritic morphogenesis. Through interaction with the glutamate receptor-interacting protein 1 (GRIP1) and myosin VI, Trip6 is crucial for the total dendritic length and the number of primary dendrites in cultured hippocampal neurons. Trip6 depletion reduces F-actin content and impairs dendritic morphology, and this phenocopies GRIP1 or myosin VI knockdown. Furthermore, phosphorylation of GRIP1956T by AKT1 inhibits the interaction between GRIP1 and myosin VI, but facilitates GRIP1 binding to 14-3-3 protein, which is required for regulating F-actin organization and dendritic morphogenesis. Thus, the Trip6–GRIP1–myosin VI interaction and its regulati...
    Feb 11, 2015 Kaosheng Lv
  • This Week in The Journal | Journal of Neuroscience
    The Battle of the LTDs in the Cerebellum Wolfgang Mittmann and Michael Häusser (see pages [5559–5570][1]) Purkinje cells provide the sole output of cerebellar cortex, thus serving as the final common pathway for cerebellar synaptic integration and plasticity. The cellular plasticity
    May 23, 2007
  • Previous
  • 49
  • 50
  • 51
  • 52
  • 53
  • Next

Featured

  • SfN Selects Kevin B. Marvel, PhD, as Next Executive Director
  • Read the Neuroscience Quarterly - Fall 2025
  • Renew your SfN Membership Today!
SfN Websites
  • BrainFacts.org logo
  • eNeuro logo
  • JNeurosci logo
  • Neuronline logo
Engage with SfN
  • join Join
  • give Give
  • advocate Advocate
  • publish Publish
Quick Links
  • SfN News
  • For Press
  • Global Events
  • Contact Us
  • Advertise
  • Code of Conduct
  • Jobs at SfN
  • SfN Store
  • Social Media
Follow SfN
  • BlueSky logo
  • Facebook logo
  • Instagram logo
  • LinkedIn logo

  • Threads logo
  • X Logo
  • YouTube logo
SfN logo with "SfN" in a blue box next to Society for Neuroscience in red text and the SfN tag line that reads "Advancing the understanding of the brain and nervous system"
1121 14th Street NW, Suite 1010, Washington, D.C. 20005
(202) 962-4000 | 1-888-985-9246
  • Accessibility Policy
  • Disclaimer
  • Privacy Notice
  • Contact Us

Copyright ©
Society for Neuroscience